MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Levodopa response is an inadequate and often biased correlate of STN-DBS outcomes

    J. Younce, S. Norris, J. Perlmutter (Chapel Hill, USA)

    Objective: To investigate the reliability of the relationship between levodopa response and subthalamic nucleus (STN) DBS outcomes in Parkinson disease (PD). Background: Levodopa response (LR)…
  • 2024 International Congress

    Clinically implemented sensing-based initial programming of deep brain stimulation for Parkinson’s disease: a retrospective study

    A. Fuentes, B. Swinnen, M. Volz, S. Heath, P. Starr, S. Little, J. Ostrem (Palo Alto, USA)

    Objective: We aimed to assess the feasibility and performance of clinically implemented sensing-based initial deep brain stimulation (DBS) programming for Parkinson’s disease (PD). Background: Initial…
  • 2024 International Congress

    Artificial Intelligence and Visual Analysis of Movements in Parkinson’s Disease

    T. Okelberry, H. Beisar, S. Horev, E. Pinchuk, K. Lyons, R. Pahwa (Kansas City, USA)

    Objective: To evaluate the use of artificial intelligence in the analysis and classification of movements in Parkinson's disease. Background: Artificial intelligence (AI) is a powerful…
  • 2024 International Congress

    Reliability of real-world walking activity and gait assessment in people with Parkinson’s disease – how many hours and days are needed?

    J. Buekers, J. Marchena, S. Koch, J. Lemos, J. Cherdova, C. Becker, T. Bonci, J. Braun, B. Caulfield, A. Frei, E. Gazit, J. Hausdorff, A. Mirelman, S. Del Din, L. Alcock, A. Yarnall, C. Jansen, M. Long, B. Sharrack, D. Singleton, C. Schlenstedt, W. Maetzler, H. Gassner, A. Ionescu, P. Ginis, A. Nieuwboer, L. Rochester, J. Garcia-Aymerich (Barcelona, Spain)

    Objective: To define i) the minimally required daily wear time during waking hours that constitutes a valid measurement of walking using digital mobility outcomes (DMOs)…
  • 2024 International Congress

    Use of social media and health information technology among caregivers of Alzheimer’s disease and other neurological conditions: Secondary analysis of the 2022 Health Information National Trend (HINTS) Survey

    M. Arbabi Kalati (Hinsdale, USA)

    Objective: This study aims to evaluate the pattern of health information seeking from social media and other health technology tools among caregivers for individuals with…
  • 2024 International Congress

    Measuring Motor Improvement with a Wearable Device in a Parkinson Disease Patient undergoing Subcutaneous Levodopa Carbidopa Infusion

    N. Lopez Ariztegui, MI. Morales Casado, G. Tabar Comellas (TOLEDO, Spain)

    Objective: To assess the feasibility of a wearable device for objective quantification of motor improvement in Parkinson's Disease (PD) patients undergoing a therapy  from oral…
  • 2024 International Congress

    Motor Onset of Parkinson’s disease: the proximal limbs are first

    MA. Ruiz Yanzi, M. Matarazzo, T. Jiménez-Castellanos, JA. Pineda-Pardo, MHG. Monje, A. Sánchez-Ferro, C. Gasca-Salas, R. Martínez-Fernández, JA. Obeso (Madrid, Spain)

    Objective: To determine if proximal body parts are more affected than distal body parts at the clinical onset of Parkinson’s disease (PD). Background: Motor features…
  • 2024 International Congress

    Mixed Cerebellar Ataxia in a Patient with a Novel FAT2 Gene Variant Associated with SCA45

    A. Richmond, M. Nashatizadeh, R. Townley (Columbia, USA)

    Objective: We describe a patient with late-onset ataxia, cognitive impairment, and parkinsonism with a novel missense variant in FAT2, a gene implicated in spinocerebellar ataxia…
  • 2024 International Congress

    Spinocerebellar Ataxia Type 4: a Novel Polyglycine Disease caused by GGC Repeat Expansion in ZFHX3.

    S. Pulst (slc, USA)

    Objective: Identification of the mutation causing SCA4. Background: SCA4 is an autosomal dominant disease, originally described in a large Utah pedigree, characterized by sensory and…
  • 2024 International Congress

    CAPRIN1 defect: a new severe neurodegenerative disorder with childhood dementia, myoclonus-ataxia, and sensorimotor neuropathy

    R. Bove, A. Torella, G. Ricciardi, L. Pollini, M. Novelli, F. Pisani, V. Nigro, V. Leuzzi, S. Galosi (Rome, Italy)

    Objective: To present the case of a patient with a severe neurodegenerative disorder with onset in pediatric age carrying a pathogenic variant in CAPRIN1 gene…
  • « Previous Page
  • 1
  • …
  • 133
  • 134
  • 135
  • 136
  • 137
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley